1. A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer. Issue 2 (December 2015) Authors: Katz, Matthew; Todd, Bauer; Varadhachary, Gauri; Acquavella, Nicolas; Petroni, Gina; Bullock, Timothy; Slingluff, Craig; Rahma, Osama Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗